Shopping Cart
- Remove All
Your shopping cart is currently empty
PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $350 | In Stock | |
| 5 mg | $828 | In Stock | |
| 10 mg | $1,130 | In Stock | |
| 25 mg | $1,590 | In Stock | |
| 50 mg | $1,980 | In Stock | |
| 100 mg | $2,500 | In Stock |
| Description | PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD). |
| Targets&IC50 | β-Amyloid (1–42):1.6 μM |
| In vitro | The MTT data for the PPI-1019 using SHY5Y cells after a 24 h aggregation of 10 μM Aβ-(1–42) with IC50 was 10 μM. The N-methylated peptides PPI-1019 show a reduction in cell toxicity at concentrations similar to that used in the thioflavin T assays (IC50=1.6 μM).[1] |
| Synonyms | PPI1019, Apan |
| Molecular Weight | 650.85 |
| Formula | C36H54N6O5 |
| Cas No. | 290828-45-4 |
| Smiles | [C@@H](CC1=CC=CC=C1)(C(N[C@H](CC2=CC=CC=C2)C(N[C@H](CC(C)C)C(N)=O)=O)=O)NC([C@H](NC([C@@H](CC(C)C)NC)=O)C(C)C)=O |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| Solubility Information | DMSO: 1 mg/mL (1.54 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
| |||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.